Bancks Michael P, Bertoni Alain G, Carnethon Mercedes, Chen Haiying, Cotch Mary Frances, Gujral Unjali P, Herrington David, Kanaya Alka M, Szklo Moyses, Vaidya Dhananjay, Kandula Namratha R
Wake Forest School of Medicine, Winston-Salem, NC, USA.
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2106-e2115. doi: 10.1210/clinem/dgaa962.
There are known disparities in diabetes complications by race and ethnicity. Although diabetes subgroups may contribute to differential risk, little is known about how subgroups vary by race/ethnicity.
Data were pooled from 1293 (46% female) participants of the Mediators of Atherosclerosis in South Asians Living in America (MASALA) and the Multi-Ethnic Study of Atherosclerosis (MESA) who had diabetes (determined by diabetes medication use, fasting glucose, and glycated hemoglobin [HbA1c]), including 217 South Asian, 240 non-Hispanic white, 125 Chinese, 387 African American, and 324 Hispanic patients. We applied k-means clustering using data for age at diabetes diagnosis, body mass index, HbA1c, and homeostatic model assessment measures of insulin resistance and beta cell function. We assessed whether diabetes subgroups were associated with race/ethnicity, concurrent cardiovascular disease risk factors, and incident diabetes complications.
Five diabetes subgroups were characterized by older age at diabetes onset (43%), severe hyperglycemia (26%), severe obesity (20%), younger age at onset (1%), and requiring insulin medication use (9%). The most common subgroup assignment was older onset for all race/ethnicities with the exception of South Asians where the severe hyperglycemia subgroup was most likely. Risk for renal complications and subclinical coronary disease differed by diabetes subgroup and, separately, race/ethnicity.
Racial/ethnic differences were present across diabetes subgroups, and diabetes subgroups differed in risk for complications. Strategies to eliminate racial/ethnic disparities in complications may need to consider approaches targeted to diabetes subgroup.
已知糖尿病并发症在种族和族裔方面存在差异。尽管糖尿病亚组可能导致不同的风险,但对于亚组如何因种族/族裔而异知之甚少。
汇总了来自美国南亚人动脉粥样硬化介导因素研究(MASALA)和多族裔动脉粥样硬化研究(MESA)的1293名(46%为女性)糖尿病患者(根据糖尿病药物使用、空腹血糖和糖化血红蛋白[HbA1c]确定)的数据,包括217名南亚人、240名非西班牙裔白人、125名中国人、387名非裔美国人和324名西班牙裔患者。我们使用糖尿病诊断时的年龄、体重指数、HbA1c以及胰岛素抵抗和β细胞功能的稳态模型评估指标进行k均值聚类。我们评估了糖尿病亚组是否与种族/族裔、并发心血管疾病危险因素以及糖尿病并发症的发生有关。
五个糖尿病亚组分别以糖尿病发病年龄较大(43%)、严重高血糖(26%)、严重肥胖(20%)、发病年龄较小(1%)和需要使用胰岛素药物(9%)为特征。除南亚人最常见的亚组分类是严重高血糖亚组外,所有种族/族裔最常见的亚组分类都是发病年龄较大。糖尿病亚组以及种族/族裔在肾脏并发症和亚临床冠状动脉疾病的风险方面存在差异。
糖尿病亚组之间存在种族/族裔差异,并且糖尿病亚组在并发症风险方面也有所不同。消除并发症方面种族/族裔差异的策略可能需要考虑针对糖尿病亚组的方法。